Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Stratification of Intermediate-Risk Acute Myeloid Leukemia According to the Expression Level of WT1 mRNA at Diagnosis

Kyoko Fuse, Kaihatsu Akane, Toshiki Kitajima, Akihito Momoi, Takuya Kasami, Takayuki Katagiri, Yasuhiko Shibasaki, Tatsuo Furukawa, Miwako Narita, Hirohito Sone, Masayoshi Masuko

Blood (2021) 138 (Supplement 1): 1286.

https://doi.org/10.1182/blood-2021-146114

Published: 2021

Journal Articles

BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma.

Jun Takizawa, Sadao Aoki, Akihito Momoi, Toshiki Kitajima, Masutaka Higashimura, Naoya Nakamura, Yoshifusa Aizawa

Blood (2006) 108 (11): 4620.

https://doi.org/10.1182/blood.V108.11.4620.4620

Published: 2006

Journal Articles

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

Jun Takizawa, MD, PhD, Sadao Aoki, MD, PhD, Kazue Takai, MD, Tohri Kurasaki, MD, Keiichiro Honma, MD, Masutaka Higashimura, MD, Kouichi Nagai, MD, Akihito Momoi, MD, PhD, Koji Nikkuni, MD, PhD, Yoshufusa Aizawa, MD

Blood (2005) 106 (11): 4734.

https://doi.org/10.1182/blood.V106.11.4734.4734

Published: 2005

Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD

Blood (2004) 104 (11): 5076.

https://doi.org/10.1182/blood.V104.11.5076.5076

Published: 2004

Journal Articles

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Sadao Aoki, MD, PhD, Jun Takizawa, MD, PhD, Masutaka Higashimura, MD, Akihito Momoi, MD, Nobuhiro Tsukada, MD, PhD, Koji Nikkuni, MD, PhD, Nobuhiko Nomoto, MD, PhD, Yoshifusa Aizawa, MD

Blood (2004) 104 (11): 5207.

https://doi.org/10.1182/blood.V104.11.5207.5207

Published: 2004

NARROW

Stratification of Intermediate-Risk Acute Myeloid Leukemia According to the Expression Level of WT1 mRNA at Diagnosis

BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma.

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Email alerts

ASH Publications

American Society of Hematology

Stratification of Intermediate-Risk Acute Myeloid Leukemia According to the Expression Level of WT1 mRNA at Diagnosis

BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma.

A Phase II Clinical Study of Rituximab and High-Dose Biweekly THP-COP (Pirarubicin, Cyclophosphamide, Vincristine and Predonisolone) with G-CSF for Non-Hodgkin Lymphoma: Results of a Multicentric Study of NMLSG (Niigata Malignant Lymphoma Study Group).

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

High-Dose Bi-Weekly THP-COP Induction Treatment Followed by High-Dose Therapy with Autologous Peripheral Blood Stem Cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only